IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
September 06, 2023 16:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor...
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
August 03, 2023 08:00 ET
|
iRadimed Corporation
Reports record revenue of $16.1 million for the second quarter of 2023GAAP diluted EPS of $0.33 and non-GAAP diluted EPS of $0.36Operating income was $5.0 million and increased by 19%Announces third...
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
July 27, 2023 08:45 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 27, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 second quarter financial results before the market...
IRADIMED CORPORATION Named a 2023 Best Small Company in America by Forbes
May 10, 2023 08:30 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), was recently named on Forbes’ latest list of America’s Best Small Companies for 2023....
IRADIMED CORPORATION Announces First Quarter 2023 Financial Results
May 04, 2023 08:30 ET
|
iRadimed Corporation
Reports record revenue of $15.5 million for the first-quarter quarter of 2023 GAAP diluted EPS of $0.27 and non-GAAP diluted EPS of $0.30 Operating income was $4.0 million and increased by 30% ...
IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th
April 27, 2023 08:30 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 27, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 first quarter financial results before the market...
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
March 06, 2023 08:45 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company,...
IRADIMED CORPORATION Issues Urgent Medical Device Correction
February 24, 2023 16:15 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 24, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) issued an Urgent Medical Device Correction Letter to notify affected customers of a...
IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend
February 02, 2023 08:00 ET
|
iRadimed Corporation
Reports fourth quarter 2022 revenue of $14.9 million, GAAP diluted EPS of $0.29 and non-GAAP diluted EPS of $0.32.Reports full-year 2022 revenue of $53.3 million, GAAP diluted EPS of $1.02 and...
IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd
January 26, 2023 10:30 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 26, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 fourth quarter financial results before the market...